174 related articles for article (PubMed ID: 29170888)
1. Booming cancer immunotherapy fighting tumors.
Li D; Wang W
Sci China Life Sci; 2017 Dec; 60(12):1445-1449. PubMed ID: 29170888
[No Abstract] [Full Text] [Related]
2. Cancer immunotherapy.
Bender E
Nature; 2017 Dec; 552(7685):S61. PubMed ID: 29293244
[No Abstract] [Full Text] [Related]
3. The Phoenix Rises: The Rebirth of Cancer Immunotherapy.
Blasutig IM; Farkona S; Buchbinder EI; Luke JJ; Sharma P; Sznol M
Clin Chem; 2017 Jul; 63(7):1190-1195. PubMed ID: 28515097
[No Abstract] [Full Text] [Related]
4. Introduction: Cancer Immunology Special Issue-Immunotherapy.
Kawakami Y
Int Immunol; 2016 Jul; 28(7):317. PubMed ID: 27313100
[No Abstract] [Full Text] [Related]
5. Cytokine therapy for cancer.
Kim-Schulze S; Taback B; Kaufman HL
Surg Oncol Clin N Am; 2007 Oct; 16(4):793-818, viii. PubMed ID: 18022545
[TBL] [Abstract][Full Text] [Related]
6. Cells and cytokines in immunotherapy and gene therapy of cancer.
Pawelec G; Rees RC; Kiessling R; Madrigal A; Dodi A; Baxevanis C; Gambacorti-Passerini C; Masucci G; Zeuthen J
Crit Rev Oncog; 1999; 10(1-2):83-127. PubMed ID: 10327211
[TBL] [Abstract][Full Text] [Related]
7. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
Nelson B
Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
[No Abstract] [Full Text] [Related]
8. Cancer vaccines based on the identification of genes encoding cancer regression antigens.
Rosenberg SA
Immunol Today; 1997 Apr; 18(4):175-82. PubMed ID: 9136454
[No Abstract] [Full Text] [Related]
9. Apoptotic vesicles as tumor vaccine.
Horrevorts SK; Garcia-Vallejo JJ; van Vliet SJ; van de Loosdrecht AA; van Kooyk Y; de Gruijl TD
Immunotherapy; 2016; 8(1):5-8. PubMed ID: 26641072
[No Abstract] [Full Text] [Related]
10. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
[TBL] [Abstract][Full Text] [Related]
11. Tumor immunology top 10 list.
Finn OJ
Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
[No Abstract] [Full Text] [Related]
12. Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions.
Berry J; Vreeland T; Trappey A; Hale D; Peace K; Tyler J; Walker A; Brown R; Herbert G; Yi F; Jackson D; Clifton G; Peoples GE
Expert Rev Clin Immunol; 2017 Mar; 13(3):235-245. PubMed ID: 27552944
[TBL] [Abstract][Full Text] [Related]
13. Active Immunotherapy of Cancer.
Chodon T; Koya RC; Odunsi K
Immunol Invest; 2015; 44(8):817-36. PubMed ID: 26575466
[TBL] [Abstract][Full Text] [Related]
14. Where have all the T cells gone? Mechanisms of immune evasion by tumors.
Finke J; Ferrone S; Frey A; Mufson A; Ochoa A
Immunol Today; 1999 Apr; 20(4):158-60. PubMed ID: 10203710
[No Abstract] [Full Text] [Related]
15. Cancer immunotherapy.
Schuster M; Nechansky A; Kircheis R
Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
[TBL] [Abstract][Full Text] [Related]
16. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
Jäger E; Jäger D; Knuth A
Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
[No Abstract] [Full Text] [Related]
17. [Cell therapy in solid tumors].
Ravaud A
Bull Cancer; 2001 Jan; 88(1):91-100. PubMed ID: 11182658
[No Abstract] [Full Text] [Related]
18. Immunotherapy: Cancer vaccines on the move.
Banchereau J; Palucka K
Nat Rev Clin Oncol; 2018 Jan; 15(1):9-10. PubMed ID: 28895570
[No Abstract] [Full Text] [Related]
19. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.
Yannelli JR; Wroblewski JM
Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713
[TBL] [Abstract][Full Text] [Related]
20. The Crookshank lecture: biological response modifiers in the treatment of cancer.
Guillou PJ
Clin Oncol (R Coll Radiol); 1990 Nov; 2(6):347-53. PubMed ID: 2278894
[No Abstract] [Full Text] [Related]
[Next] [New Search]
